08 Jan 2020 Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture Investors | News | Therapeutics
20 Jun 2019 Avacta and Selexis partner to develop cell line for clinical manufacturing Investors | Therapeutics
12 Jun 2019 Avacta’s Chief Scientific Officer to Present at Major US Conference Investors | Therapeutics
03 Jun 2019 TMAC Programme Accelerates: Clinical Trial Planned for Early 2020 Investors | Therapeutics